The new prognostic factor for pulmonary embolism: The ratio of monocyte count to HDL cholesterol

Am J Emerg Med. 2021 Aug:46:212-216. doi: 10.1016/j.ajem.2020.07.026. Epub 2020 Jul 16.

Abstract

Purpose: Aim of this study is to investigate effectiveness of the monocyte to HDL cholesterol ratio in patients diagnosed with pulmonary embolism for predicting intra-hospital mortality.

Method: A total of 269 patients diagnosed with pulmonary embolism in the emergency clinic were included in the study. Study was conducted retrospectively. Pulmonary Embolism Severity Index (PESI), Monocyte count and high density lipoprotein cholesterol (HDL) values were determined. MHR values of the patients were calculated. SPSS 26 package program was used to investigate the effectiveness of MHR in predicting mortality.

Findings: Mean age of the patients was 64.51 ± 12.4 years. PESI, Number of monocytes and MHR were significantly higher in the group with mortality than the group without mortality (p < .05). HDL values were significantly lower (p < .05) in mortality group. Sensitivity of MHR 19 cut off value was 89.3%, and its specificity was 82.0%.

Conclusion: Use of predictors for mortality estimation in patients diagnosed with acute pulmonary embolism is important for faster administration of treatment modalities. We think MHR values can be used as a strong predictor according to the hemogram parameters and biochemical results.

Keywords: HDL cholesterol; MHR; Monocyte; Mortality; PESI; Pulmonary embolism.

MeSH terms

  • Aged
  • Biomarkers / blood
  • Cholesterol, HDL / blood*
  • Hospital Mortality*
  • Humans
  • Middle Aged
  • Monocytes*
  • Predictive Value of Tests
  • Prognosis
  • Pulmonary Embolism / blood*
  • Pulmonary Embolism / mortality*

Substances

  • Biomarkers
  • Cholesterol, HDL